SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 414.48+0.7%Jan 9 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (182819)1/18/2022 9:16:14 AM
From: Pogeu Mahone  Read Replies (1) of 219212
 


×
Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests (bloomberg.com) 129
Posted by BeauHD on Monday January 17, 2022 @05:40PM from the better-than-nothing dept.

A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday. Bloomberg reports:Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Aviv, researchers found the vaccine successfully raised antibody levels. But that only offered a partial defense against omicron, according to Gili Regev-Yochay, the trial's lead researcher. Vaccines which were more effective against previous variants offer less protection with omicron, she said. Still, those infected in the trial had only slight symptoms or none at all.

Israel started rolling out the fourth dose of the vaccine to the over-60s and immunocompromised in late December amid a surge in cases. Since then, more than half a million Israelis have received the extra dose, according to the Health Ministry. The decision to give the fourth vaccine to the most vulnerable was the correct one, Regev-Yochay said at a virtual press conference, since it may have given additional benefit against omicron. But she added the results didn't support a wider rollout to the whole population.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News